AGTR1 and hypertensive disorder: Suppression of the overexcited local RAS in the brain could be a strategy for drug development for hypertension, targeting astrocytes in the cardiovascular brain regions, such as a blood-brain barrier penetrating AT1R blocker75 or a blocker of astrocytic activation59.